Major effects on blood-retina barrier passage by minor alterations in design of polybutylcyanoacrylate nanoparticles
- 26 November 2018
- journal article
- research article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 27 (3) , 338-346
Abstract
Because the blood-brain barrier (BBB) is an obstacle for drug-delivery, carrier systems such as polybutylcyanoacrylate (PBCA) nanoparticles (NPs) have been studied. Yet, little is known of how physiochemical features such as size, surfactants and surface charge influence BBB passage in vivo. We now used a rat model of in vivo imaging of the retina - which is brain tissue and can reflect the situation at the BBB - to study how size and surface charge determine NPs’ ability to cross the blood-retina barrier (BRB). Interestingly, for poloxamer 188-modified, DEAE-dextran-stabilized, fluorescent PBCA NPs, decreasing the average zeta-size from 272 nm to 172 nm by centrifugation reduced the BRB passage of the NPs substantially. Varying the zeta potential within the narrow range of 0 – 15 mV by adding different amounts of stabilizer revealed that 0 mV and 15 mV were less desirable than 5 mV which facilitated the BRB passage. Moreover, whether the fluorescent marker was adsorbed or incorporated also influenced the transport into the retina tissue. Thus, minor changes in design of nano-carriers can alter physicochemical parameters such as size or zeta potential, thus substantially influencing NPs’ biological distribution in vivo, possibly by interactions with blood constituents and peripheral organs.Keywords
Funding Information
- German Research Foundation (SA433/28–1)
- China Scholarship Council (201406370149)
- ERA.Net RUS Plus initiative (ID#169; NABUCO)
- Deutsche Forschungsgemeinschaft
This publication has 33 references indexed in Scilit:
- Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulationFluids and Barriers of the CNS, 2012
- Blood-Retinal BarrierEuropean Journal of Ophthalmology, 2010
- In vivo confocal neuroimaging (ICON): non‐invasive, functional imaging of the mammalian CNS with cellular resolutionEuropean Journal of Neuroscience, 2010
- DEAE-Dextran Transfection of Lymphocyte Cell LinesCold Spring Harbor Protocols, 2010
- Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseasesNeurobiology of Disease, 2010
- Evolutionary Conservation of Vertebrate Blood–Brain Barrier Chemoprotective Mechanisms inDrosophilaJournal of Neuroscience, 2009
- Two faces of calcium activation after optic nerve trauma: life or death of retinal ganglion cells in vivo depends on calcium dynamicsEuropean Journal of Neuroscience, 2007
- Lipid composition determines interaction of liposome membranes with Pluronic L61Biochimica et Biophysica Acta (BBA) - Biomembranes, 2005
- In vitro model of the outer blood–retina barrierBrain Research Protocols, 2004
- Restoration of vision IIINeuroReport, 1999